These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 404869)

  • 21. An atypical von Willebrand's disease with hyperreactivity of platelet aggregation.
    Niiya K; Kubonishi I; Taguchi H; Miyoshi I
    Acta Haematol; 1984; 71(3):158-64. PubMed ID: 6424380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using a monoclonal antibody to identify patients with type I and type II von Willebrand's disease.
    Hall JD; Willis DW; Evatt BL; Jackson DW
    Thromb Haemost; 1987 Jun; 57(3):332-6. PubMed ID: 3116703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Von Willebrand's syndrome. Studies on a variant factor VIII.
    Hill FG; Chan MC; Hardisty RM
    Haemostasis; 1976; 5(5):276-84. PubMed ID: 797643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simple enzyme-immunoassay (EIA) test for factor VIII-related antigen (VIIIAGN).
    Ness PM; Perkins HA
    Thromb Haemost; 1979 Oct; 42(3):848-54. PubMed ID: 116386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
    Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
    Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases.
    Sampson BM; Greaves M; Malia RG; Preston FE
    Br J Haematol; 1983 Jun; 54(2):233-44. PubMed ID: 6405778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Factor VIII-like antigen in haemophilia A and in Willebrand's disease (author's transl)].
    Blatný J; Procházka J; Bártová A; Fischerová E; Slepicka L; Skodová M
    Cas Lek Cesk; 1975 Sep; 114(38):1174-6. PubMed ID: 1081010
    [No Abstract]   [Full Text] [Related]  

  • 30. A simplified method for the production of heterologous antiserum to factor VIII related antigen.
    Yang HC; Duffy C; Levine PH
    Thromb Res; 1977 Oct; 11(4):463-70. PubMed ID: 411194
    [No Abstract]   [Full Text] [Related]  

  • 31. [Advances in hematology. Willebrand's disease and hemophilia A in the light of latest studies of the factor VIII].
    Zawilska K
    Pol Arch Med Wewn; 1976 Aug; 56(8):179-84. PubMed ID: 787944
    [No Abstract]   [Full Text] [Related]  

  • 32. A comparison of five different rabbit antisera to factor VIII and the demonstration of a factor VIII related antigen in normal and von Willebrand's disease platelets.
    Shearn SA; Giddings JC; Peake IR; Bloom AL
    Thromb Res; 1974 Nov; 5(5):585-99. PubMed ID: 4614489
    [No Abstract]   [Full Text] [Related]  

  • 33. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
    Dowling SV; Muntz RH; D'Souza S; Ekert H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis of von Willebrand's disease by means of the quantitative immunological assay of factor VIII-related antigen (author's transl)].
    Gruson R; Kernoff PB
    Dtsch Med Wochenschr; 1974 Aug; 99(31):1593-5. PubMed ID: 4210557
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ristocetin-induced platelet aggregation in von Willebrand's disease, thrombasthenia and essential athrombia with special reference to AHF-like antigen (author's transl)].
    Ishiguro J; Kondo M; Ogata K; Takahashi T; Kamiya T
    Rinsho Ketsueki; 1975 Jul; 16(7):716-24. PubMed ID: 1080812
    [No Abstract]   [Full Text] [Related]  

  • 36. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor VIII-related antigen in canine hemophilia and Von Willebrand's disease: Variation when measured with different agaroses.
    Benson RE; Bouma BN; Dodds WJ
    Thromb Res; 1975 Sep; 7(3):383-9. PubMed ID: 1081282
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence that factor VIII and the ristocetin aggregating factor (VIIIRist) are separate molecular entities.
    Hougie C; Sargeant RB; Brown JE; Baugh RF
    Proc Soc Exp Biol Med; 1974 Oct; 147(1):58-61. PubMed ID: 4548194
    [No Abstract]   [Full Text] [Related]  

  • 39. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An immunoradiometric assay for procoagulant factor VIII antigen: results in haemophilia, von Willebrand's disease and fetal plasma and serum.
    Peake IR; Bloom AL; Giddings JC; Ludlam CA
    Br J Haematol; 1979 Jun; 42(2):269-81. PubMed ID: 313808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.